IGMS
IGM Biosciences
IGMS
IGMS
Delisted
IGMS was delisted on the 13th of August, 2025.
107 hedge funds and large institutions have $1.52B invested in IGM Biosciences in 2020 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 32 increasing their positions, 32 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
107
Holders Change
+16
Holders Change %
+17.58%
% of All Funds
1.9%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.05%
New
30
Increased
32
Reduced
32
Closed
14
Calls
$5.37M
Puts
$33.5M
Net Calls
-$28.1M
Net Calls Change
-$24.2M
Top Buyers
| 1 |
AG
Artal Group
Luxembourg
|
+$45.1M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$40.7M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
+$39.7M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$33.1M |
| 5 |
BlackRock
New York
|
+$23.5M |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$30.3M |
| 2 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$17.5M |
| 3 |
VC
Vivo Capital
Palo Alto,
California
|
-$7.37M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.08M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$1.96M |
